Other names: Imigran

Each Imitrex tablet contains 50 mg. sumatriptan succinate. Imitrex, marketed in Europe and Asia under the brand name Imigran.

 

Imitrex (Imigran, Sumatriptan) tablets contain the active ingredient sumatriptan succinate. Imitrex belongs to a group of drugs called serotonin agonists.

 

Imitrex tablets are used to relieve a migraine attack. Imitrex should not be used to prevent migraine attacks from occurring. Imitrex tablets may be used for migraine headaches with or without what is known as 'aura'. It is thought that migraine headache is due to widening of certain blood vessels in the head. Imitrex tablets work by making those vessels normal again and ease the symptoms of migraine. Imitrex tablets do not work in other types of headache which are not a migraine. Imitrex tablets are not addictive. The recommended starting dose for adults is 50 mg, however you may need to have your dose of Imitrex tablets increased to 100 mg. If the first Imitrex tablet helps your migraine, but the migraine comes back later, you may take another Imitrex tablet. Do not take more than 300 mg of Imitrex tablets in any twenty-four hours.

 

Imitrex (Imigran, Sumatriptan) is used to relieve a migraine attack. Imitrex should not be used to prevent migraine attacks from occurring. Imitrex may be used for migraine headaches with or without what is known as 'aura'. It is thought that migraine headache is due to widening of certain blood vessels in the head. Imitrex work by making those vessels normal again and ease the symptoms of migraine. Imitrex does not work in other types of headache which are not a migraine.

 

 

Imitrex comes as a tablet, containing 50 mg of the active ingredient sumatriptan succinate, to take by mouth.

Imitrex is intended to relieve migraine, but not to prevent or reduce the number of attacks. Use Imitrex only to treat an actual migraine attack.

 

For adults, the usual dose is a single tablet taken whole with fluids. A second tablet may be taken if the symptoms of migraine come back or if the initial dose have given only a partial response, but not sooner than 2 hours following the first tablet. For a given attack, if the first tablet has given no response, do not take a second tablet without first consulting with your doctor. Do not take more than a total of 200 mg of Imitrex in any 24-hour period.

 

Do not take Imitrex if you have ever had an allergic reaction to sumatriptan succinate or you have or have had heart disease or heart attack, shortness of breath, pain or tightness in the chest, jaw or upper arm, peripheral vascular disease or are prone to cold, tingling or numb hands and feet, Prinzmetal's angina, angina, high blood pressure, stroke or severe liver disease.

 

There are no adequate and well-controlled studies in pregnant women. Therefore, Imitrex should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Sumatriptan is excreted in human breast milk. Therefore, caution should be exercised when considering the administration of Imitrex to a nursing woman.

 

 

Like other medicines, Imitrex can cause some side effects. They can include pain, tingling, heat or flushing in any part of the body, a feeling of sleepiness, dizziness, tiredness, nausea, vomiting, a change in blood pressure, a feeling of faintness and problems with your eyesight. In any case do not take any more Imitrex and contact your doctor. If you notice other effects not listed above, contact your doctor.

 

If overdose of Imitrex is suspected, contact your local poison control center or emergency room immediately.

 

Keep Imitrex in a tightly closed container and out of reach of children. Store Imitrex at room temperature and away from excess heat and moisture (not in the bathroom). For more information about Imitrex, please see GlaxoSmithKline, Imitrex product information.